# Blend to Limit Oxygen in ECMO: A Randomised Controlled Registry Trial

Study · id `cardio:ct-nct03841084` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03841084](<https://clinicaltrials.gov/study/NCT03841084>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03841084

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 300 participants.

## Technical summary

Registry record NCT03841084. Randomized; no masking; primary purpose treatment. Start 2019-09-18 (actual); primary completion 2023-06-03 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 300 participants (enrolled count; ClinicalTrials.gov record NCT03841084, source copy `cardio:ctgov-nct03841084-2024-08-09`, retrieved 2026-10-26)
- Started: 2019-09-18 (actual) (ClinicalTrials.gov record NCT03841084, source copy `cardio:ctgov-nct03841084-2024-08-09`, retrieved 2026-10-26)
- Primary completion: 2023-06-03 (actual) (ClinicalTrials.gov record NCT03841084, source copy `cardio:ctgov-nct03841084-2024-08-09`, retrieved 2026-10-26)
- Completion: 2023-07-01 (actual) (ClinicalTrials.gov record NCT03841084, source copy `cardio:ctgov-nct03841084-2024-08-09`, retrieved 2026-10-26)
- Countries: Australia (ClinicalTrials.gov record NCT03841084, source copy `cardio:ctgov-nct03841084-2024-08-09`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03841084-2024-08-09`, retrieved 2026-10-26)

## The registry's words

- Brief title: Blend to Limit Oxygen in ECMO: A Randomised Controlled Registry Trial
- Acronym: BLENDER
- Condition: Cardiac Failure
- Condition: Critical Illness
- Intervention (Drug): Oxygen
- Lead sponsor: Australian and New Zealand Intensive Care Research Centre
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Conservative or liberal oxygen targets in patients on venoarterial extracorporeal membrane oxygenation (`cardio:pubmed-39162827`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 0299a0522fc1761dae645f2ccb6e7e7ad9d7bfe6fb51e6a64324c652d29ec755
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
